Bivalirudin Injection, Powder, Lyophilized, For Solution
Product Images NDC 83634-400

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 83634-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Biv08 0001 01)

Chemical structure of bivalirudin, depicted with detailed molecular bonds and groups, including annotations indicating the presence of trifluoroacetic acid (CF3CO2H) with a variable composition range (X=1.9-2.6). This illustrates the peptide structure of bivalirudin used in injection form.*

FDA Label Image

Figure (Biv08 0001 02)

Label for Bivalirudin injection, powder, lyophilized for solution, 250 mg per vial. This single-dose vial is for intravenous use only. The label includes dosage strength, storage instructions, and manufacturer information for Avenacy, Inc. A barcode and NDC 83634-400 are visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.